ELDN - Eledon Pharmaceuticals, Inc. Common Stock -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Eledon Pharmaceuticals, Inc. Common Stock
IPO Date: September 17, 2014
Sector: Healthcare
Industry: Biotech
Market Cap: $212.9M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.16 | 4.12%
Avg Daily Range (30 D): $0.10 | 3.23%
Avg Daily Range (90 D): $0.12 | 3.31%
Institutional Daily Volume
Avg Daily Volume: .35M
Avg Daily Volume (30 D): .79M
Avg Daily Volume (90 D): 1.02M
Trade Size
Avg Trade Size (Sh.): 158
Avg Trade Size (Sh.) (30 D): 118
Avg Trade Size (Sh.) (90 D): 127
Institutional Trades
Total Institutional Trades: 87
Avg Institutional Trade: $1.4M
Avg Institutional Trade (30 D): $.63M
Avg Institutional Trade (90 D): $1.45M
Avg Institutional Trade Volume: .41M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.7M
Avg Closing Trade (30 D): $.62M
Avg Closing Trade (90 D): $1.51M
Avg Closing Volume: 498.57K
 
News
Nov 14, 2025 @ 10:00 PM
Eledon Pharmaceuticals Announces Recent Business H...
Source: David-Alexandre C. Gros, M.D.
Nov 6, 2025 @ 11:30 PM
Eledon Presents Phase 2 BESTOW Trial Results for T...
Source: Eledon Pharmaceuticals
Oct 17, 2025 @ 11:00 AM
Eledon Pharmaceuticals to Present Results from Pha...
Source: Eledon Pharmaceuticals
Aug 29, 2025 @ 11:00 AM
Eledon Pharmaceuticals to Participate in Cantor Gl...
Source: David-Alexandre C. Gros
Aug 6, 2025 @ 5:00 PM
Global Renal Transplant Therapeutics Market is Exp...
Source: Delveinsight
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-.91 $-.27 $-.33
Diluted EPS $-.91 $-.27 $-.33
Revenue $M $M
Gross Profit
Net Income / Loss $-98.56M $-31.63M $-39.03M
Operating Income / Loss $-22.87M $-21.18M
Cost of Revenue
Net Cash Flow $1.06M $-16.01M $M
PE Ratio    
Splits
Oct 05, 2020 1:18